Caloric restriction in leptin deficiency does not correct myocardial steatosis : failure to normalize PPAR{alpha}/PGC1{alpha} and thermogenic glycerolipid/fatty acid cycling
OBJECTIVE: Evidence supports an antilipotoxic role for leptin in preventing inappropriate peripheral tissue lipid deposition. Obese, leptin-deficient mice develop left ventricular (LV) hypertrophy and myocardial steatosis with increased apoptosis and decreased longevity. Here we investigated the cardiac effects of caloric restriction versus leptin repletion in obese leptin-deficient (ob/ob) mice.
METHODS: Echocardiography was performed on 7 mo old C57BL/6 wild-type mice (WT) and ob/ob mice fed ad libitum, leptin-repleted (LR-ob/ob), or calorie-restricted (CR-ob/ob) for 4 wk. Ventricular tissue was examined by electron microscopy (EM), triglyceride (TAG) content, oil red O staining, mitochondrial coupling assay, and microarray expression profiling.
RESULTS: LR and CR-ob/ob mice showed decreased body and heart weight, and LV wall thickness compared with ad libitum ob/ob mice. LV fractional shortening was decreased in ad libitum ob/ob mice, but restored to WT in LR and CR groups. However, myocardial lipid content by EM and TAG analysis revealed persistent cardiac steatosis in the CR-ob/ob group. Although CR restored mitochondrial coupling to WT levels, PPARα was suppressed and genes associated with oxidative stress and cell death were upregulated in CR-ob/ob animals. In contrast, LR eliminated cardiac steatosis, normalized mitochondrial coupling, and restored PGC1α and PPARα expression, while inducing core genes involved in glycerolipid/free fatty acid (GL/FFA) cycling, a thermogenic pathway that can reduce intracellular lipids.
CONCLUSIONS: Thus, CR in the absence of leptin fails to normalize cardiac steatosis. GL/FFA cycling may be, at least in part, leptin-dependent and a key pathway that protects the heart from lipid accumulation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2011 |
|---|---|
| Erschienen: |
2011 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Physiological genomics - 43(2011), 12 vom: 28. Juni, Seite 726-38 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rame, J Eduardo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 04.11.2011 Date Revised 20.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1152/physiolgenomics.00088.2010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM206855435 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM206855435 | ||
| 003 | DE-627 | ||
| 005 | 20231224000834.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1152/physiolgenomics.00088.2010 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0690.xml |
| 035 | |a (DE-627)NLM206855435 | ||
| 035 | |a (NLM)21427359 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rame, J Eduardo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Caloric restriction in leptin deficiency does not correct myocardial steatosis |b failure to normalize PPAR{alpha}/PGC1{alpha} and thermogenic glycerolipid/fatty acid cycling |
| 264 | 1 | |c 2011 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.11.2011 | ||
| 500 | |a Date Revised 20.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a OBJECTIVE: Evidence supports an antilipotoxic role for leptin in preventing inappropriate peripheral tissue lipid deposition. Obese, leptin-deficient mice develop left ventricular (LV) hypertrophy and myocardial steatosis with increased apoptosis and decreased longevity. Here we investigated the cardiac effects of caloric restriction versus leptin repletion in obese leptin-deficient (ob/ob) mice | ||
| 520 | |a METHODS: Echocardiography was performed on 7 mo old C57BL/6 wild-type mice (WT) and ob/ob mice fed ad libitum, leptin-repleted (LR-ob/ob), or calorie-restricted (CR-ob/ob) for 4 wk. Ventricular tissue was examined by electron microscopy (EM), triglyceride (TAG) content, oil red O staining, mitochondrial coupling assay, and microarray expression profiling | ||
| 520 | |a RESULTS: LR and CR-ob/ob mice showed decreased body and heart weight, and LV wall thickness compared with ad libitum ob/ob mice. LV fractional shortening was decreased in ad libitum ob/ob mice, but restored to WT in LR and CR groups. However, myocardial lipid content by EM and TAG analysis revealed persistent cardiac steatosis in the CR-ob/ob group. Although CR restored mitochondrial coupling to WT levels, PPARα was suppressed and genes associated with oxidative stress and cell death were upregulated in CR-ob/ob animals. In contrast, LR eliminated cardiac steatosis, normalized mitochondrial coupling, and restored PGC1α and PPARα expression, while inducing core genes involved in glycerolipid/free fatty acid (GL/FFA) cycling, a thermogenic pathway that can reduce intracellular lipids | ||
| 520 | |a CONCLUSIONS: Thus, CR in the absence of leptin fails to normalize cardiac steatosis. GL/FFA cycling may be, at least in part, leptin-dependent and a key pathway that protects the heart from lipid accumulation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, N.I.H., Intramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Leptin |2 NLM | |
| 650 | 7 | |a Lipids |2 NLM | |
| 650 | 7 | |a PPAR alpha |2 NLM | |
| 700 | 1 | |a Barouch, Lili A |e verfasserin |4 aut | |
| 700 | 1 | |a Sack, Michael N |e verfasserin |4 aut | |
| 700 | 1 | |a Lynn, Edward G |e verfasserin |4 aut | |
| 700 | 1 | |a Abu-Asab, Mones |e verfasserin |4 aut | |
| 700 | 1 | |a Tsokos, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Kern, Steven J |e verfasserin |4 aut | |
| 700 | 1 | |a Barb, Jennifer J |e verfasserin |4 aut | |
| 700 | 1 | |a Munson, Peter J |e verfasserin |4 aut | |
| 700 | 1 | |a Halushka, Marc K |e verfasserin |4 aut | |
| 700 | 1 | |a Miller, Karen L |e verfasserin |4 aut | |
| 700 | 1 | |a Fox-Talbot, Karen |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Jianhua |e verfasserin |4 aut | |
| 700 | 1 | |a Hare, Joshua M |e verfasserin |4 aut | |
| 700 | 1 | |a Solomon, Michael A |e verfasserin |4 aut | |
| 700 | 1 | |a Danner, Robert L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Physiological genomics |d 1997 |g 43(2011), 12 vom: 28. Juni, Seite 726-38 |w (DE-627)NLM097535508 |x 1531-2267 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2011 |g number:12 |g day:28 |g month:06 |g pages:726-38 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1152/physiolgenomics.00088.2010 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2011 |e 12 |b 28 |c 06 |h 726-38 | ||